During the past 12 months, Techno Medical PCL's average EBITDA Per Share Growth Rate was 88.20% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 24.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -4.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -10.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Techno Medical PCL was 24.30% per year. The lowest was -37.50% per year. And the median was -9.05% per year.
Techno Medical PCL (BKK:TM-R) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Techno Medical PCL 5-Year EBITDA Growth Rate Related Terms
BKK:TM-R vs MCK, CAH, COR: 5-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, Techno Medical PCL's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL 5-Year EBITDA Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's 5-Year EBITDA Growth Rate falls into.
Techno Medical PCL 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of -4.70% mean?
Techno Medical PCL (BKK:TM-R) has a 5-Year EBITDA Growth Rate of -4.70% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Techno Medical PCL and its competitors.
Is Techno Medical PCL's 5-Year EBITDA Growth Rate too high?
Techno Medical PCL's current 5-Year EBITDA Growth Rate is -4.70%. Overall, Techno Medical PCL has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's 5-Year EBITDA Growth Rate compare to MCK and CAH?
Techno Medical PCL's 5-Year EBITDA Growth Rate of -4.70% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Medical Distribution company?
A good 5-Year EBITDA Growth Rate depends on the Medical Distribution industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Techno Medical PCL and its competitors. Techno Medical PCL's current 5-Year EBITDA Growth Rate is -4.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current 5-Year EBITDA Growth Rate of -4.70%. The stock's GF Value™ is ฿2.99, compared to a current price of ฿2.32 — trading 22.4% below its estimated fair value. The current 5-Year EBITDA Growth Rate is -4.70%. Techno Medical PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current 5-Year EBITDA Growth Rate is -4.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 22.4% below its estimated GF Value™ of ฿2.99.
Key valuation signals for BKK:TM-R:
5-Year EBITDA Growth Rate: -4.70%
GF Value™: ฿2.99 vs. price of ฿2.32 (22.4% below fair value)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
77GF Score
Get the complete analysis for BKK:TM-R
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 